Tranexamic Acid Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) injection
Available Strengths: 100 mg/mL in 5 mL, 10 mL, or 100 mL vials
Reference Brands: Cyklokapron®(US & EU)
Category:
Critical Care
Tranexamic Acid, an antifibrinolytic, prevents excessive bleeding in surgeries and trauma. Available in 500 mg tablets and 100 mg/mL IV injections, it’s marketed as Cyklokapron®, Lysteda®, and Exacyl®. Pharma B2B platforms offer global buyers compliant, bulk sourcing of tranexamic acid from trusted, GMP-certified manufacturers.
Tranexamic Acid is available in Intravenous (IV) injection
and strengths such as 100 mg/mL in 5 mL, 10 mL, or 100 mL vials.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tranexamic Acid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tranexamic Acid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tranexamic Acid is an antifibrinolytic agent used to reduce or prevent excessive bleeding in surgical, trauma, and gynecological settings. Available in IV and oral forms, it is commonly supplied as 100 mg/mL injection or 500 mg tablets. Leading brands include Cyklokapron® (Pfizer), Lysteda® (Ferring), and Exacyl® (Sanofi). Widely adopted in both emergency medicine and elective surgeries, tranexamic acid helps stabilize clots and minimize transfusion needs. Pharma B2B platforms provide access to GMP-certified tranexamic acid products in bulk quantities, supporting hospitals, surgical centers, and emergency care providers with reliable global sourcing and compliance with US and EU pharmaceutical standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing